Table 1.
Patients’ baseline characteristics (n = 121)
| Age (years) | 62 ± 9 |
| Women, n (%) | 50 (41) |
| Diabetes duration (years) | 9 ± 8 |
| Smoking habit, n (%) | 30 (25) |
| Past history of cardiovascular diseases n (%) | 17 (14) |
| Past history of cerebro-cardiovascular diseases n (%) | 10 (8) |
| Family history of cardiovascular diseases, n (%) | 74 (61) |
| Systolic blood pressure (mmHg) | 128 ± 11 |
| Diastolic blood pressure (mmHg) | 79 ± 8 |
| Hypertension, n (%) | 93 (77) |
| Obesity, n (%) | 68 (56) |
| Dyslipidemia, n (%) | 93 (77) |
| Use of anti-hypertensive therapies | |
| Beta-blockers, n (%) | 18 (15) |
| Angiotensin-converting enzyme inhibitors, n (%) | 29 (24) |
| Calcium entry blockers, n (%) | 12 (10) |
| Diuretics, n (%) | 28 (23) |
| Use of lipid-lowering drugs | |
| Statins, n (%) | 57 (47) |
| Fibrates, n (%) | 3 (3) |
| Omega-3 fatty acids, n (%) | 14 (13) |
| Aspirin use, n (%) | 43 (35) |
n number